TECH vs TEM
Bio-Techne Corp (TECH) versus Tempus AI, Inc. Class A Common Stock (TEM) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Tempus AI, Inc. Class A Common Stock (TEM) is a health information services company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TEM revenue for 2024-12-31 was $693.4M. Net income was -$705.8M. Revenue was up 30.4% from 2023-12-31 to 2024-12-31. TEM currently screens at market cap $8.76B.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TEM currently screens at market cap $8.76B.
Not investment advice. Open the TECH and TEM stock pages for the full models.
Not investment advice.